Bristol-Myers Squibb Company operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bristol-Myers Squibb Company with three other companies in this sector in UNITED STATES : Eli Lilly and Company (2019 sales of $22.32 billion of which 100% was Human Pharmaceuticals products), Abbott Laboratories ($31.90 billion of which 38% was Medical Devices), and AstraZeneca PLC ($24.38 billion of which 100% was BioPharmaceuticals).

Sales Analysis. During the year ended December of 2019, sales at Bristol-Myers Squibb Company were $26.15 billion. This is an increase of 15.9% versus 2018, when the company's sales were $22.56 billion. This was the fifth consecutive year of sales increases at Bristol-Myers Squibb Company (and since 2014, sales have increased a total of 65%).